<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="186">
  <stage>Registered</stage>
  <submitdate>12/08/2005</submitdate>
  <approvaldate>23/08/2005</approvaldate>
  <actrnumber>ACTRN12605000202662</actrnumber>
  <trial_identification>
    <studytitle>A randomised controlled trial of cognitive remediation in psychosis</studytitle>
    <scientifictitle>A randomised controlled trial of cognitive remediation in the treatment of cognitive deficits in schizophrenia</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Schizophrenia</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Schizophrenia</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Computer assisted cognitive remediation
immediate treatment </interventions>
    <comparator>A wait-list control</comparator>
    <control>Historical</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Improvement in cognitive deficits</outcome>
      <timepoint>At the end of treatment and at 15 weeks post treatment</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Improvement in negative symptoms</outcome>
      <timepoint>At end of treatment and at 15 weeks post treatment.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Quality of life</outcome>
      <timepoint>At end of treatment and at 15 weeks post treatment.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Social function and self esteem</outcome>
      <timepoint>At end of treatment and at 15 weeks post treatment.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Diagnosis of schizophrenia, cognitive deficit of &gt; 1 SD below premorbid functioning, stable medication for 2 months, stable residence.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>55</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Mental retardation, non-english speaking, current substance abuse, significant head injury or neurological condition, ECT in past 6 months.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation was by coin toss at time of randomisation therefore allocation concealment was not required</concealment>
    <sequence>coin toss</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures>Wait list control</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>10/01/2003</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>80</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Anthony Harris</primarysponsorname>
    <primarysponsoraddress>Department of Psychiatry Westmead Hospital Westmead NSW 2145</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Eli Lilly Australia</fundingname>
      <fundingaddress>112 Wharf Road West Ryde NSW 2114</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Perpetual Trustees</fundingname>
      <fundingaddress>GPO Box 4172 Sydney NSW 2001</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Schizophrenia Fellowship of NSW Research Trust Fund</fundingname>
      <fundingaddress>Locked Bag 5014 Gladesville NSW 1675</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sydney West Area Health Service Human Research Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Western Sydney and Wentworth AHS</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Northern Sydney AHS Human Research Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Anthony Harris</name>
      <address>Department of Psychiatry
Westmead Hospital
Westmead NSW 2145</address>
      <phone>+61 2 98456688</phone>
      <fax>+61 2 96357734</fax>
      <email>aharris1@mail.usyd.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Anthony Harris</name>
      <address>Department of Psychiatry Westmead Hospital Westmead NSW 2145</address>
      <phone>+61 2 98456688</phone>
      <fax>+61 2 96357734</fax>
      <email>aharris1@mail.usyd.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Anthony Harris</name>
      <address>Department of Psychiatry Westmead Hospital Westmead NSW 2145</address>
      <phone>+61 2 98456688</phone>
      <fax>+61 2 96357734</fax>
      <email>aharris1@mail.usyd.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>